Literature DB >> 25083208

Quantifying nonsteroidal anti-inflammatory drug (NSAID) risk: can combining the evidence with the use of a network meta-analysis provide a solution?

Richard John Woodman1.   

Abstract

Year:  2011        PMID： 25083208      PMCID： PMC4110859          DOI： 10.1177/2042098611412108

Source DB:  PubMed          Journal:  Ther Adv Drug Saf        ISSN： 2042-0986


× No keyword cloud information.
  8 in total

1.  Validity of indirect comparison for estimating efficacy of competing interventions: empirical evidence from published meta-analyses.

Authors:  Fujian Song; Douglas G Altman; Anne-Marie Glenny; Jonathan J Deeks
Journal:  BMJ       Date:  2003-03-01

2.  Network meta-analysis for indirect treatment comparisons.

Authors:  Thomas Lumley
Journal:  Stat Med       Date:  2002-08-30       Impact factor: 2.373

3.  Indirect comparisons: the mesh and mess of clinical trials.

Authors:  John P A Ioannidis
Journal:  Lancet       Date:  2006-10-28       Impact factor: 79.321

4.  A case study of multiple-treatments meta-analysis demonstrates that covariates should be considered.

Authors:  Georgia Salanti; Valeria Marinho; Julian P T Higgins
Journal:  J Clin Epidemiol       Date:  2009-01-20       Impact factor: 6.437

Review 5.  Evaluation of networks of randomized trials.

Authors:  Georgia Salanti; Julian P T Higgins; A E Ades; John P A Ioannidis
Journal:  Stat Methods Med Res       Date:  2007-10-09       Impact factor: 3.021

6.  Indirect comparisons of competing interventions.

Authors:  A M Glenny; D G Altman; F Song; C Sakarovitch; J J Deeks; R D'Amico; M Bradburn; A J Eastwood
Journal:  Health Technol Assess       Date:  2005-07       Impact factor: 4.014

Review 7.  Cardiovascular safety of non-steroidal anti-inflammatory drugs: network meta-analysis.

Authors:  Sven Trelle; Stephan Reichenbach; Simon Wandel; Pius Hildebrand; Beatrice Tschannen; Peter M Villiger; Matthias Egger; Peter Jüni
Journal:  BMJ       Date:  2011-01-11

8.  Combination of direct and indirect evidence in mixed treatment comparisons.

Authors:  G Lu; A E Ades
Journal:  Stat Med       Date:  2004-10-30       Impact factor: 2.373
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.